Eintrag weiter verarbeiten

Microsatellite instability and Beta2-Microglobulin mutations as prognostic markers in colon cancer: results of the FOGT-4 trial

Gespeichert in:

Veröffentlicht in: British journal of cancer 106(2012), 6, Seite 1239-1245
Personen und Körperschaften: Schulz, Anna (VerfasserIn), Knebel Doeberitz, Magnus von (VerfasserIn), Kloor, Matthias (VerfasserIn)
Titel: Microsatellite instability and Beta2-Microglobulin mutations as prognostic markers in colon cancer: results of the FOGT-4 trial/ A. Tikidzhieva, A. Benner, S. Michel, A. Formentini, K.-H. Link, W. Dippold, M. von Knebel Doeberitz, M. Kornmann and M. Kloor
Format: E-Book-Kapitel
Sprache: Englisch
veröffentlicht:
21 February 2012
Gesamtaufnahme: : British journal of cancer, 106(2012), 6, Seite 1239-1245
, volume:106
Quelle: Verbunddaten SWB
Lizenzfreie Online-Ressourcen
LEADER 03851caa a2200577 4500
001 0-1575856409
003 DE-627
005 20220814151832.0
007 cr uuu---uuuuu
008 180530s2012 xx |||||o 00| ||eng c
024 7 |a 10.1038/bjc.2012.53  |2 doi 
035 |a (DE-627)1575856409 
035 |a (DE-576)505856409 
035 |a (DE-599)BSZ505856409 
035 |a (OCoLC)1341010401 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
100 1 |a Schulz, Anna  |d 1984-  |e VerfasserIn  |0 (DE-588)1057967998  |0 (DE-627)796229406  |0 (DE-576)413967948  |4 aut 
245 1 0 |a Microsatellite instability and Beta2-Microglobulin mutations as prognostic markers in colon cancer  |b results of the FOGT-4 trial  |c A. Tikidzhieva, A. Benner, S. Michel, A. Formentini, K.-H. Link, W. Dippold, M. von Knebel Doeberitz, M. Kornmann and M. Kloor 
264 1 |c 21 February 2012 
300 |a 7 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 30.05.2018 
520 |a Background: High-level microsatellite instability (MSI-H) has been reported as a prognostic marker in colon cancer. We here analysed the prognostic significance of MSI and mutations of the Beta2-Microglobulin (B2M) gene, which occur in about 30% of MSI-H colon cancer, in the cohort of the prospective FOGT-4 (Forschungsruppe Onkologie Gastrointestinale Tumoren, FOGT) trial. Methods: Microsatellite instability status was determined using standard protocols (NCI/ICG-HNPCC panel and CAT25) in 223 colon cancer lesions. Beta2-Microglobulin mutation status was evaluated by exon-wise sequencing in all MSI-H lesions. Results: Patients with MSI-H (n=34) colon cancer presented with a significantly lower risk of relapse after 12 months of follow-up compared with MSS (n=189) colon cancer patients (5 year time to relapse: MSI-H 0.82 vs MSS 0.66, P=0.03). No significant difference in overall survival was detected. Beta2-Microglobulin mutations were identified in 10 (29.4%) out of 34 MSI-H colon cancers and were associated with a complete absence of disease relapse or tumour-related death events (P=0.09). Conclusion: The risk of late disease relapse was significantly lower in patients with MSI-H compared with MSS colon cancer. Moreover, B2M mutations may contribute to the favourable outcome of MSI-H colon cancer patients and should therefore be evaluated as a potential prognostic marker in future clinical trials. 
700 1 |a Knebel Doeberitz, Magnus von  |e VerfasserIn  |0 (DE-588)1022165291  |0 (DE-627)71693289X  |0 (DE-576)364934239  |4 aut 
700 1 |a Kloor, Matthias  |d 1972-  |e VerfasserIn  |0 (DE-588)124552803  |0 (DE-627)363416609  |0 (DE-576)294228616  |4 aut 
773 0 8 |i Enthalten in  |t British journal of cancer  |d Edinburgh : Nature Publ. Group, 1999  |g 106(2012), 6, Seite 1239-1245  |h Online-Ressource  |w (DE-627)320420094  |w (DE-600)2002452-6  |w (DE-576)103746854  |x 1532-1827  |7 nnns 
773 1 8 |g volume:106  |g year:2012  |g number:6  |g pages:1239-1245  |g extent:7 
856 4 0 |u http://dx.doi.org/10.1038/bjc.2012.53  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://www.nature.com/articles/bjc201253  |x Verlag  |z kostenfrei  |3 Volltext 
936 u w |d 106  |j 2012  |e 6  |h 1239-1245  |g 7 
951 |a AR 
856 4 0 |u https://www.nature.com/articles/bjc201253  |9 LFER 
852 |a LFER  |z 2019-05-07T00:00:00Z 
970 |c OD 
971 |c EBOOK 
972 |c EBOOK 
973 |c Aufsatz 
935 |a lfer 
900 |a Tikidzhieva, Anna 
900 |a Kloor, Matthias Johannes 
900 |a Knebel Döberitz, Magnus von 
900 |a Knebel-Doeberitz, Magnus von 
900 |a Doeberitz, Magnus Knebel von 
900 |a Doeberitz, Magnus K. von 
900 |a Knebel Doeberitz, M. von 
951 |b XA-DE 
951 |b XA-RU 
980 |a 1575856409  |b 0  |k 1575856409  |o 505856409  |c lfer 
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Microsatellite+instability+and+Beta2-Microglobulin+mutations+as+prognostic+markers+in+colon+cancer%3A+results+of+the+FOGT-4+trial&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Adc&rft.creator=Schulz%2C+Anna&rft.pub=&rft.format=Journal&rft.language=English&rft.issn=1532-1827
SOLR
_version_ 1757949574849232896
access_facet Electronic Resources
author Schulz, Anna, Knebel Doeberitz, Magnus von, Kloor, Matthias
author_facet Schulz, Anna, Knebel Doeberitz, Magnus von, Kloor, Matthias
author_role aut, aut, aut
author_sort Schulz, Anna 1984-
author_variant a s as, d m v k dmv dmvk, m k mk
callnumber-sort
collection lfer
container_reference 106(2012), 6, Seite 1239-1245
container_title British journal of cancer
contents Background: High-level microsatellite instability (MSI-H) has been reported as a prognostic marker in colon cancer. We here analysed the prognostic significance of MSI and mutations of the Beta2-Microglobulin (B2M) gene, which occur in about 30% of MSI-H colon cancer, in the cohort of the prospective FOGT-4 (Forschungsruppe Onkologie Gastrointestinale Tumoren, FOGT) trial. Methods: Microsatellite instability status was determined using standard protocols (NCI/ICG-HNPCC panel and CAT25) in 223 colon cancer lesions. Beta2-Microglobulin mutation status was evaluated by exon-wise sequencing in all MSI-H lesions. Results: Patients with MSI-H (n=34) colon cancer presented with a significantly lower risk of relapse after 12 months of follow-up compared with MSS (n=189) colon cancer patients (5 year time to relapse: MSI-H 0.82 vs MSS 0.66, P=0.03). No significant difference in overall survival was detected. Beta2-Microglobulin mutations were identified in 10 (29.4%) out of 34 MSI-H colon cancers and were associated with a complete absence of disease relapse or tumour-related death events (P=0.09). Conclusion: The risk of late disease relapse was significantly lower in patients with MSI-H compared with MSS colon cancer. Moreover, B2M mutations may contribute to the favourable outcome of MSI-H colon cancer patients and should therefore be evaluated as a potential prognostic marker in future clinical trials.
ctrlnum (DE-627)1575856409, (DE-576)505856409, (DE-599)BSZ505856409, (OCoLC)1341010401
doi_str_mv 10.1038/bjc.2012.53
facet_avail Online, Free
finc_class_facet not assigned
footnote Gesehen am 30.05.2018
format ElectronicBookComponentPart
format_access_txtF_mv Article, E-Article
format_de105 Ebook
format_de14 Article, E-Article
format_de15 Article, E-Article
format_del152 Buch
format_detail_txtF_mv text-online-monograph-child
format_dezi4 e-Book
format_finc Article, E-Article
format_legacy ElectronicBookPart
format_strict_txtF_mv E-Article
geogr_code not assigned
geogr_code_person Germany, Russia
hierarchy_parent_id 0-320420094
hierarchy_parent_title British journal of cancer
hierarchy_sequence 106(2012), 6, Seite 1239-1245
hierarchy_top_id 0-320420094
hierarchy_top_title British journal of cancer
id 0-1575856409
illustrated Not Illustrated
imprint 21 February 2012
imprint_str_mv 21 February 2012
institution DE-D117, DE-105, LFER, DE-Ch1, DE-15, DE-14, DE-Zwi2
is_hierarchy_id 0-1575856409
is_hierarchy_title Microsatellite instability and Beta2-Microglobulin mutations as prognostic markers in colon cancer: results of the FOGT-4 trial
isil_str_mv LFER
issn 1532-1827
kxp_id_str 1575856409
language English
last_indexed 2023-02-16T01:35:58.075Z
marc024a_ct_mv 10.1038/bjc.2012.53
match_str schulz2012microsatelliteinstabilityandbeta2microglobulinmutationsasprognosticmarkersincoloncancerresultsofthefogt4trial
mega_collection Verbunddaten SWB, Lizenzfreie Online-Ressourcen
misc_de105 EBOOK
multipart_link 103746854
multipart_part (103746854)106(2012), 6, Seite 1239-1245
names_id_str_mv (DE-588)1057967998, (DE-627)796229406, (DE-576)413967948, (DE-588)1022165291, (DE-627)71693289X, (DE-576)364934239, (DE-588)124552803, (DE-627)363416609, (DE-576)294228616
oclc_num 1341010401
physical 7
publishDate 21 February 2012
publishDateSort 2012
publishPlace
publisher
record_format marcfinc
record_id 505856409
recordtype marcfinc
rvk_facet No subject assigned
source_id 0
spelling Schulz, Anna 1984- VerfasserIn (DE-588)1057967998 (DE-627)796229406 (DE-576)413967948 aut, Microsatellite instability and Beta2-Microglobulin mutations as prognostic markers in colon cancer results of the FOGT-4 trial A. Tikidzhieva, A. Benner, S. Michel, A. Formentini, K.-H. Link, W. Dippold, M. von Knebel Doeberitz, M. Kornmann and M. Kloor, 21 February 2012, 7, Text txt rdacontent, Computermedien c rdamedia, Online-Ressource cr rdacarrier, Gesehen am 30.05.2018, Background: High-level microsatellite instability (MSI-H) has been reported as a prognostic marker in colon cancer. We here analysed the prognostic significance of MSI and mutations of the Beta2-Microglobulin (B2M) gene, which occur in about 30% of MSI-H colon cancer, in the cohort of the prospective FOGT-4 (Forschungsruppe Onkologie Gastrointestinale Tumoren, FOGT) trial. Methods: Microsatellite instability status was determined using standard protocols (NCI/ICG-HNPCC panel and CAT25) in 223 colon cancer lesions. Beta2-Microglobulin mutation status was evaluated by exon-wise sequencing in all MSI-H lesions. Results: Patients with MSI-H (n=34) colon cancer presented with a significantly lower risk of relapse after 12 months of follow-up compared with MSS (n=189) colon cancer patients (5 year time to relapse: MSI-H 0.82 vs MSS 0.66, P=0.03). No significant difference in overall survival was detected. Beta2-Microglobulin mutations were identified in 10 (29.4%) out of 34 MSI-H colon cancers and were associated with a complete absence of disease relapse or tumour-related death events (P=0.09). Conclusion: The risk of late disease relapse was significantly lower in patients with MSI-H compared with MSS colon cancer. Moreover, B2M mutations may contribute to the favourable outcome of MSI-H colon cancer patients and should therefore be evaluated as a potential prognostic marker in future clinical trials., Knebel Doeberitz, Magnus von VerfasserIn (DE-588)1022165291 (DE-627)71693289X (DE-576)364934239 aut, Kloor, Matthias 1972- VerfasserIn (DE-588)124552803 (DE-627)363416609 (DE-576)294228616 aut, Enthalten in British journal of cancer Edinburgh : Nature Publ. Group, 1999 106(2012), 6, Seite 1239-1245 Online-Ressource (DE-627)320420094 (DE-600)2002452-6 (DE-576)103746854 1532-1827 nnns, volume:106 year:2012 number:6 pages:1239-1245 extent:7, http://dx.doi.org/10.1038/bjc.2012.53 Verlag Resolving-System kostenfrei Volltext, https://www.nature.com/articles/bjc201253 Verlag kostenfrei Volltext, https://www.nature.com/articles/bjc201253 LFER, LFER 2019-05-07T00:00:00Z
spellingShingle Schulz, Anna, Knebel Doeberitz, Magnus von, Kloor, Matthias, Microsatellite instability and Beta2-Microglobulin mutations as prognostic markers in colon cancer: results of the FOGT-4 trial, Background: High-level microsatellite instability (MSI-H) has been reported as a prognostic marker in colon cancer. We here analysed the prognostic significance of MSI and mutations of the Beta2-Microglobulin (B2M) gene, which occur in about 30% of MSI-H colon cancer, in the cohort of the prospective FOGT-4 (Forschungsruppe Onkologie Gastrointestinale Tumoren, FOGT) trial. Methods: Microsatellite instability status was determined using standard protocols (NCI/ICG-HNPCC panel and CAT25) in 223 colon cancer lesions. Beta2-Microglobulin mutation status was evaluated by exon-wise sequencing in all MSI-H lesions. Results: Patients with MSI-H (n=34) colon cancer presented with a significantly lower risk of relapse after 12 months of follow-up compared with MSS (n=189) colon cancer patients (5 year time to relapse: MSI-H 0.82 vs MSS 0.66, P=0.03). No significant difference in overall survival was detected. Beta2-Microglobulin mutations were identified in 10 (29.4%) out of 34 MSI-H colon cancers and were associated with a complete absence of disease relapse or tumour-related death events (P=0.09). Conclusion: The risk of late disease relapse was significantly lower in patients with MSI-H compared with MSS colon cancer. Moreover, B2M mutations may contribute to the favourable outcome of MSI-H colon cancer patients and should therefore be evaluated as a potential prognostic marker in future clinical trials.
swb_id_str 505856409
title Microsatellite instability and Beta2-Microglobulin mutations as prognostic markers in colon cancer: results of the FOGT-4 trial
title_auth Microsatellite instability and Beta2-Microglobulin mutations as prognostic markers in colon cancer results of the FOGT-4 trial
title_full Microsatellite instability and Beta2-Microglobulin mutations as prognostic markers in colon cancer results of the FOGT-4 trial A. Tikidzhieva, A. Benner, S. Michel, A. Formentini, K.-H. Link, W. Dippold, M. von Knebel Doeberitz, M. Kornmann and M. Kloor
title_fullStr Microsatellite instability and Beta2-Microglobulin mutations as prognostic markers in colon cancer results of the FOGT-4 trial A. Tikidzhieva, A. Benner, S. Michel, A. Formentini, K.-H. Link, W. Dippold, M. von Knebel Doeberitz, M. Kornmann and M. Kloor
title_full_unstemmed Microsatellite instability and Beta2-Microglobulin mutations as prognostic markers in colon cancer results of the FOGT-4 trial A. Tikidzhieva, A. Benner, S. Michel, A. Formentini, K.-H. Link, W. Dippold, M. von Knebel Doeberitz, M. Kornmann and M. Kloor
title_in_hierarchy Microsatellite instability and Beta2-Microglobulin mutations as prognostic markers in colon cancer: results of the FOGT-4 trial / A. Tikidzhieva, A. Benner, S. Michel, A. Formentini, K.-H. Link, W. Dippold, M. von Knebel Doeberitz, M. Kornmann and M. Kloor,
title_short Microsatellite instability and Beta2-Microglobulin mutations as prognostic markers in colon cancer
title_sort microsatellite instability and beta2 microglobulin mutations as prognostic markers in colon cancer results of the fogt 4 trial
title_sub results of the FOGT-4 trial
url http://dx.doi.org/10.1038/bjc.2012.53, https://www.nature.com/articles/bjc201253